All content on this website ("the Site") is the property of . The collection and assembly of content on this Site are the exclusive property of and are protected by copyright and other intellectual property laws. We do not asset any claims of copyright for ICD 10 information or HCPCS Codes. ICD 10 ( International Statistical Classification of Diseases and Related Health Problems 10) is a copyright of the World Health Organization (WHO). HCPCS data is from the United States Centers for Medicare & Medicaid Services (CMS) and is from the 2019 HCPCS data edition. All HCPCS (Healthcare Common Procedure Coding System) codes are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). HCPCS procedure and descriptions are copyright to the American Medical Association (AMA). We claim no copyright over these. Inclusion of exlusion of a procedure, supply, product, or service does not imply any health insurance coverage or reimbursement policy. In some instances, brand names may appear in HCPCS descriptions. HCPCS has included these for indexing purposes only and their inclusion does not convey endorsement of any particular brand. We assume no responsibility or liability for any errors or omissions in the content of this site. Please use at your own risk.
All content on this website ("the Site") is the property of . The collection and assembly of content on this Site are the exclusive property of and are protected by copyright and other intellectual property laws. We do not asset any claims of copyright for ICD 10 information or HCPCS Codes. ICD 10 ( International Statistical Classification of Diseases and Related Health Problems 10) is a copyright of the World Health Organization (WHO). HCPCS data is from the United States Centers for Medicare & Medicaid Services (CMS) and is from the 2019 HCPCS data edition. All HCPCS (Healthcare Common Procedure Coding System) codes are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). HCPCS procedure and descriptions are copyright to the American Medical Association (AMA). We claim no copyright over these. Inclusion of exlusion of a procedure, supply, product, or service does not imply any health insurance coverage or reimbursement policy. In some instances, brand names may appear in HCPCS descriptions. HCPCS has included these for indexing purposes only and their inclusion does not convey endorsement of any particular brand. We assume no responsibility or liability for any errors or omissions in the content of this site. Please use at your own risk.
Was this site helpful to you? We would very much appreciate you whitelisting us or using this link when you shop on Amazon (no impact on your order).
Description: Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)
Description: Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen
Description: Direct (face-to-face with patient) skilled nursing services of a registered nurse provided in a comprehensive outpatient rehabilitation facility, each 10 minutes beyond the first 5 minutes
Description: Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
Description: Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Description: Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Description: Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Description: Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Description: Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Description: Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Description: Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Description: Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
Description: Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Was this site helpful to you? We would very much appreciate you whitelisting us or using this link when you shop on Amazon (no impact on your order).
Was this site helpful to you? We would very much appreciate you whitelisting us or using this link when you shop on Amazon (no impact on your order).
â
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.